Biomarkers

A Way of Predicting if New Psychosis Patients Will or Won’t Respond to Standard Treatment
“Trial and error” remains the basis for care of people who have recently been diagnosed with psychosis, and “poor outcomes are common,” say a team of researchers at the University of California,… Read More
Brain Scans Reveal a Possible Biomarker for Suicidal Thoughts in PTSD
Researchers have used brain scanning technology to confirm a relationship between levels of a common type of receptor and the risk for suicidal thinking in people with post-traumatic stress disorder… Read More
Different Response Patterns to TMS Treatment for Major Depression Point to Possibility of Individualized Treatments
It may soon be possible to make individualized treatment plans for different subsets of patients with treatment-resistant major depression, using a type of non-invasive brain stimulation therapy… Read More
Developing Neuroscience Tools to Improve Treatments
Psychiatry, says Dr. Daniel Pine, is at a crossroads. The two crossing paths can be labeled “clinically-focused diagnosis” and “patient-oriented biological understanding” of mental illness. Beginning… Read More
Continuing the Conversation with Dr. Pine Biomarkers That Can Make a Difference
Psychiatry, says Dr. Daniel S. Pine, “might achieve a needed paradigm shift” by adopting a research approach used in other branches of medicine, an approach called “experimental medicine.” It… Read More